Skip to content
AwardedSpainGoods€2,166,965

Adquisición de la especialidad farmacéutica PHESGO® 1200 mg/600 mg solución para inyección y PHESGO® 600 mg/600 mg solución para inyección (Pertuzumab/Trastuzumab)

Published
Published 10 June 2026

Overview

Hospital Universitario Ramón y Cajal has awarded a contract to Roche Farma SAU for the supply of the pharmaceutical specialty PHESGO® (Pertuzumab/Trastuzumab) in two formulations: 1200 mg/600 mg and 600 mg/600 mg solution for injection, for use by the hospital's pharmacy service. The contract value is €2,166,965.20, awarded on 5 May 2026.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€2,166,965
Procedure
Direct
Published
10 June 2026
Classification (CPV)
Medical consumables

Award outcome

Awarded value
€2,166,965
Award date
5 May 2026
Winner
  • ROCHE FARMA SAU

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 June 2026

Contracting authority

  • HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

    Procuring entity

    Madrid, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Adquisición de la especialidad farmacéutica PHESGO® 1200 mg/600 mg solución para inyección y PHESGO® 600 mg/600 mg solución para inyección (Pertuzumab/Trastuzumab) — won by ROCHE FARMA SAU — Skim